Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation

Transplant Infectious Disease : an Official Journal of the Transplantation Society
B Wirk, J R Wingard

Abstract

Abstract: Strongyloides stercoralis is endemic in tropical, subtropical, and even temperate regions, and infects up to 100 million people worldwide. The diagnosis of strongyloidiasis can be difficult because of intermittent larval output in stool and nonspecific symptoms with mild peripheral eosinophilia. In this case report, a patient with acute myelogenous leukemia underwent peripheral blood hematopoietic stem cell transplantation (HSCT) and was subsequently diagnosed with strongyloidiasis. Strongyloidiasis should be considered in immunocompromised patients from endemic areas who have unexplained peripheral eosinophilia. If screening tests are positive for S. stercoralis or if a patient has unexplained eosinophilia with even a remote history of travel to or residence in endemic areas, then ivermectin should be given before HSCT to prevent often fatal hyperinfection syndrome from occurring after HSCT.

References

Aug 1, 1990·American Journal of Epidemiology·T W GyorkosJ D MacLean
Mar 1, 1987·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·P B Nielsen, M Mojon
Sep 1, 1995·The American Journal of Tropical Medicine and Hygiene·Y SatoY Shiroma
Mar 1, 1994·AJR. American Journal of Roentgenology·J H WoodringJ C Reed
Dec 1, 1996·The American Journal of Tropical Medicine and Hygiene·L S MansfieldG A Schad
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A A Siddiqui, S L Berk
Apr 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Beate SteinerEmil C Reisinger
Jun 20, 2003·Bone Marrow Transplantation·H OrlentJ Apperley
Jan 17, 2004·Clinical Microbiology Reviews·Paul B Keiser, Thomas B Nutman
Dec 2, 2004·Expert Opinion on Pharmacotherapy·Rafael Igual-AdellDavid Rodríguez-Calabuig
Feb 19, 2005·Journal of Clinical Gastroenterology·Ronald ConchaArvey I Rogers
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Melanie Walker, Joseph R Zunt
Jul 18, 2006·Bone Marrow Transplantation·M H QazilbashR E Champlin
May 26, 2007·The American Journal of Medicine·David R BoulwarePatricia F Walker
Oct 18, 2007·The Annals of Pharmacotherapy·Marisel Segarra-Newnham

❮ Previous
Next ❯

Citations

Feb 11, 2011·Current Infectious Disease Reports·Luis A MarcosEduardo Gotuzzo
Oct 8, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison C RoxbyAjit P Limaye
Feb 21, 2013·Current Opinion in Pulmonary Medicine·Travis S Henry, Kristopher W Cummings
Aug 25, 2010·Current Opinion in Infectious Diseases·Martin MontesNicolas Barros
Feb 12, 2013·BMC Infectious Diseases·Dora BuonfrateZeno Bisoffi
Mar 29, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Geir Christian Enli MordalTina Namtvedt
Apr 30, 2009·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Francisco M Marty
Sep 8, 2010·Transfusion·Edward Snyder, Jacquelyn Choate
Jun 11, 2010·Transplant Infectious Disease : an Official Journal of the Transplantation Society·M A FitzpatrickM G Ison
Jun 4, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A P IoriC Girmenia
Mar 29, 2014·Experimental Biology and Medicine·Samson S Y WongKwok-Yung Yuen
Nov 20, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Jonathan D AlpernJaime S Green
Dec 9, 2016·The American Journal of Tropical Medicine and Hygiene·Adrián Sánchez-MontalváIsrael Molina
Sep 22, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·José Antonio Tesser PoloniTiana Tasca
Jul 3, 2019·Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology·George Vasquez-RiosAngélica Terashima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Transactions of the Royal Society of Tropical Medicine and Hygiene
Vinita AgrawalUday C Ghoshal
Clinical Microbiology Reviews
Paul B Keiser, Thomas B Nutman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A A Siddiqui, S L Berk
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Alison C RoxbyAjit P Limaye
© 2021 Meta ULC. All rights reserved